vs
AtriCure, Inc.（ATRC）与JBG SMITH Properties（JBGS）财务数据对比。点击上方公司名可切换其他公司
AtriCure, Inc.的季度营收约是JBG SMITH Properties的1.1倍（$141.2M vs $127.6M），AtriCure, Inc.净利率更高（0.1% vs -18.1%，领先18.1%），AtriCure, Inc.同比增速更快（14.3% vs 5.7%），过去两年AtriCure, Inc.的营收复合增速更高（10.2% vs -2.9%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
JBG SMITH Properties是一家总部位于马里兰州贝塞斯达的上市房地产投资信托公司，专注于持有并运营房地产资产，是美国商业地产领域的专业运营机构，面向市场提供多元化的不动产投资与管理服务。
ATRC vs JBGS — 直观对比
营收规模更大
ATRC
是对方的1.1倍
$127.6M
营收增速更快
ATRC
高出8.5%
5.7%
净利率更高
ATRC
高出18.1%
-18.1%
两年增速更快
ATRC
近两年复合增速
-2.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $141.2M | $127.6M |
| 净利润 | $108.0K | $-23.0M |
| 毛利率 | 77.4% | — |
| 营业利润率 | 23.0% | — |
| 净利率 | 0.1% | -18.1% |
| 营收同比 | 14.3% | 5.7% |
| 净利润同比 | — | 57.1% |
| 每股收益（稀释后） | $0.00 | $-0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCJBGS
| Q1 26 | $141.2M | $127.6M | ||
| Q4 25 | $140.5M | $127.6M | ||
| Q3 25 | $134.3M | $123.9M | ||
| Q2 25 | $136.1M | $126.5M | ||
| Q1 25 | $123.6M | $120.7M | ||
| Q4 24 | $124.3M | $130.8M | ||
| Q3 24 | $115.9M | $136.0M | ||
| Q2 24 | $116.3M | $135.3M |
净利润ATRCJBGS
| Q1 26 | $108.0K | $-23.0M | ||
| Q4 25 | — | $-45.5M | ||
| Q3 25 | $-267.0K | $-28.6M | ||
| Q2 25 | $-6.2M | $-19.2M | ||
| Q1 25 | $-6.7M | $-45.7M | ||
| Q4 24 | — | $-59.9M | ||
| Q3 24 | $-7.9M | $-27.0M | ||
| Q2 24 | $-8.0M | $-24.4M |
毛利率ATRCJBGS
| Q1 26 | 77.4% | — | ||
| Q4 25 | 75.0% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 74.9% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 74.7% | — |
营业利润率ATRCJBGS
| Q1 26 | 23.0% | — | ||
| Q4 25 | 1.8% | -47.5% | ||
| Q3 25 | 0.2% | -27.5% | ||
| Q2 25 | -4.5% | -18.4% | ||
| Q1 25 | -4.8% | -44.7% | ||
| Q4 24 | -11.7% | -53.6% | ||
| Q3 24 | -6.4% | -22.4% | ||
| Q2 24 | -6.2% | -24.3% |
净利率ATRCJBGS
| Q1 26 | 0.1% | -18.1% | ||
| Q4 25 | — | -35.7% | ||
| Q3 25 | -0.2% | -23.1% | ||
| Q2 25 | -4.5% | -15.2% | ||
| Q1 25 | -5.5% | -37.9% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | -6.8% | -19.8% | ||
| Q2 24 | -6.9% | -18.0% |
每股收益（稀释后）ATRCJBGS
| Q1 26 | $0.00 | $-0.32 | ||
| Q4 25 | $0.04 | $-0.76 | ||
| Q3 25 | $-0.01 | $-0.48 | ||
| Q2 25 | $-0.13 | $-0.29 | ||
| Q1 25 | $-0.14 | $-0.56 | ||
| Q4 24 | $-0.33 | $-0.70 | ||
| Q3 24 | $-0.17 | $-0.32 | ||
| Q2 24 | $-0.17 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.2M | — |
| 总债务越低越好 | $61.0M | — |
| 股东权益账面价值 | $491.7M | — |
| 总资产 | $644.0M | $4.3B |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCJBGS
| Q1 26 | $146.2M | — | ||
| Q4 25 | $167.4M | $75.3M | ||
| Q3 25 | $147.9M | $64.4M | ||
| Q2 25 | $117.8M | $61.4M | ||
| Q1 25 | $99.9M | $81.3M | ||
| Q4 24 | $122.7M | $145.8M | ||
| Q3 24 | $130.3M | $137.0M | ||
| Q2 24 | $114.0M | $163.5M |
总债务ATRCJBGS
| Q1 26 | $61.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — |
股东权益ATRCJBGS
| Q1 26 | $491.7M | — | ||
| Q4 25 | $491.9M | $1.2B | ||
| Q3 25 | $476.5M | $1.2B | ||
| Q2 25 | $464.5M | $1.3B | ||
| Q1 25 | $454.6M | $1.6B | ||
| Q4 24 | $461.0M | $1.8B | ||
| Q3 24 | $465.0M | $1.9B | ||
| Q2 24 | $462.1M | $2.0B |
总资产ATRCJBGS
| Q1 26 | $644.0M | $4.3B | ||
| Q4 25 | $654.2M | $4.4B | ||
| Q3 25 | $635.4M | $4.4B | ||
| Q2 25 | $608.8M | $4.5B | ||
| Q1 25 | $591.6M | $4.7B | ||
| Q4 24 | $609.3M | $5.0B | ||
| Q3 24 | $615.1M | $5.2B | ||
| Q2 24 | $597.3M | $5.3B |
负债/权益比ATRCJBGS
| Q1 26 | 0.12× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage management | $48.4M | 34% |
| Open ablation | $39.1M | 28% |
| Other | $25.0M | 18% |
| Pain management | $22.4M | 16% |
| Minimally invasive ablation | $6.4M | 5% |
JBGS
| Property rental | $105.9M | 83% |
| Third-party real estate services, including reimbursements | $17.2M | 13% |
| Other revenue | $4.5M | 4% |
